Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing.

[1]  Yang Sun,et al.  Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation , 2022, Journal for ImmunoTherapy of Cancer.

[2]  J. M. Crawford,et al.  Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy , 2022, Annals of surgery.

[3]  P. Yue,et al.  Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer , 2022, Redox biology.

[4]  Madeline G. Andrews,et al.  Challenges of Organoid Research. , 2022, Annual review of neuroscience.

[5]  James M. McFarland,et al.  Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer , 2021, Cell.

[6]  Roger B. Davis,et al.  Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer. , 2021, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  K. Yeoh,et al.  Mapping the genomic diaspora of gastric cancer , 2021, Nature Reviews Cancer.

[8]  M. Lutolf,et al.  Next-generation cancer organoids , 2021, Nature Materials.

[9]  E. Voest,et al.  Tumor organoids: Opportunities and challenges to guide precision medicine. , 2021, Cancer cell.

[10]  Jae Hyun Kim,et al.  PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  V. Cerullo,et al.  Patient-Derived Organoids for Precision Cancer Immunotherapy , 2021, Cancer Research.

[12]  Yumin Wang,et al.  Progress of Gastric Cancer Surgery in the era of Precision Medicine , 2021, International journal of biological sciences.

[13]  B. Badgwell,et al.  Current treatment and recent progress in gastric cancer , 2021, CA: a cancer journal for clinicians.

[14]  Wentao Liu,et al.  Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer , 2020, Nature Communications.

[15]  H. Clevers,et al.  Establishment of patient-derived cancer organoids for drug-screening applications , 2020, Nature Protocols.

[16]  A. Azmi,et al.  Gastric cancer: a comprehensive review of current and future treatment strategies , 2020, Cancer and Metastasis Reviews.

[17]  H. Grabsch,et al.  Gastric cancer , 2020, The Lancet.

[18]  C. Kuo,et al.  Organoid Models of Tumor Immunology , 2020, Trends in immunology.

[19]  Y. Khader,et al.  Survival Rate of Gastric Cancer Patients in Jordan: Secondary Data Analysis , 2020, JMIR public health and surveillance.

[20]  Ling Wei,et al.  Noncoding RNAs in gastric cancer: implications for drug resistance , 2020, Molecular Cancer.

[21]  Hanlee P. Ji,et al.  Single-Cell Genomic Characterization Reveals the Cellular Reprogramming of the Gastric Tumor Microenvironment , 2020, Clinical Cancer Research.

[22]  Zev A. Binder,et al.  A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity , 2019, Cell.

[23]  R. Medzhitov,et al.  Harnessing innate immunity in cancer therapy , 2019, Nature.

[24]  Hans Clevers,et al.  Cancer modeling meets human organoid technology , 2019, Science.

[25]  Ligang Xia,et al.  The roles of extracellular vesicles in gastric cancer development, microenvironment, anti-cancer drug resistance, and therapy , 2019, Molecular Cancer.

[26]  Mechthild Krause,et al.  Human gastric cancer modelling using organoids , 2018, Gut.

[27]  Chiara Sabatti,et al.  Organoid Modeling of the Tumor Immune Microenvironment , 2018, Cell.

[28]  Hans Clevers,et al.  A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening. , 2018, Cell stem cell.

[29]  R. Aft,et al.  Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids. , 2018, Lab on a chip.

[30]  G. Lee,et al.  Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3) , 2018, Gastric Cancer.

[31]  Robert E Denroche,et al.  Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. , 2018, Cancer discovery.

[32]  H. Clevers,et al.  Organoids in cancer research , 2018, Nature Reviews Cancer.

[33]  Andrea Sottoriva,et al.  Patient-derived organoids model treatment response of metastatic gastrointestinal cancers , 2018, Science.

[34]  Hans Clevers,et al.  A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity , 2018, Cell.

[35]  Bon-Kyoung Koo,et al.  Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening , 2017, Nature Medicine.

[36]  S. Takenoshita,et al.  Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan , 2017, Gastric Cancer.

[37]  E. Vasile,et al.  HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research , 2016, International journal of cancer.

[38]  M. Schwab,et al.  Role of ABC transporters in fluoropyrimidine-based chemotherapy response. , 2015, Advances in cancer research.

[39]  Manuel Hidalgo,et al.  Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.

[40]  Peter E. Czabotar,et al.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy , 2013, Nature Reviews Molecular Cell Biology.

[41]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[42]  L. Coussens,et al.  CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. , 2009, Cancer cell.

[43]  Wang Hy,et al.  Neoadjuvant chemotherapy versus none for resectable gastric cancer (Review) , 2007 .